A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer
Clinical trial NCT03047616 · COMPLETED
Trial details
- NCT number
- NCT03047616
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-11-22
- Primary completion
- 2019-01-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.